Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
54/100
Pipeline Velocity
22/100
Trial Completion Rate
57/100
Pipeline Concentration
100/100
Pipeline Freshness
65/100
Activity
Last 14 days
RESTRICT : International Multicenter Outcomes of Transcatheter Pulmonary Flow Restrictors in Congenital and Acquired Heart Disease
Influence of Bodily Practices on the Quality of Life of Women
An International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)